University of California, San Diego
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).
University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.
University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.
Top-decile sponsor footprint
University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
775 total, page 13 of 16
NAPLS Omega-3 Fatty Acid Versus Placebo Study
NCT01429454
Smoking Cessation in Hospitalized Smokers
NCT01289275
Reach for Health Study: Obesity-related Mechanisms and Mortality in Breast Cancer Survivors
NCT01302379
Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation
NCT01398280
Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab
NCT01402544
Ablation of Ventricular Fibrillation by Accurate Targeting of Arrhythmogenic Regions (AVATAR)
NCT01492764
Safety of Rt-PA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery
NCT01220739
Antipsychotic Effects of Oxytocin
NCT01621737
Monoamine Contributions to Neurocircuitry in Eating Disorders
NCT02020408
SMART: A Social and Mobile Weight Control Program for Young Adults
NCT01200459
Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
NCT01272531
Personalized Text Messages to Improve Antiretroviral Treatment (ART) Adherence in HIV+ Methamphetamine Users
NCT01317277
Ultrasound-Guided Continuous Sciatic Nerve Blocks: Popliteal Versus Subgluteal Catheters
NCT01325012
Effect of Milnacipran on Pain in Fibromyalgia
NCT01288807
The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
NCT01505179
Multilevel Intervention for Physical Activity in Retirement Communities
NCT01155011
24-hour IOP-lowering Effect of 0.01% Bimatoprost
NCT01271686
Nitisinone (NTBC) In Different Age Groups Of Patients With Alkaptonuria
NCT01390077
The Maintenance of Human Atrial Fibrillation
NCT01248156
Smoking Cessation With the Nicotine Patch: A Pilot Study of Patch Messaging
NCT01287377
Parents as the Agent of Change for Childhood Obesity
NCT01197443
Effects of Interscalene Brachial Plexus Nerve Blocks on the Hand and Forearm
NCT01229683
Continuous Popliteal Nerve Blocks: Effect of Perineural Catheter Tip Location Relative to the Sciatic Nerve Bifurcation on Postoperative Analgesia
NCT01229696
Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks
NCT01231204
Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection
NCT01434706
Exposure Therapy for Fear of Falling in Older Adults
NCT01609322
Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
NCT01199575
Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma
NCT01554410
Exploring Behavioral Interventions to Improve Heart Failure
NCT01625819
Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
NCT01402531
A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH)
NCT01198418
Development of a Personalized Real-time Intervention for Bipolar Disorder
NCT01670123
Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) Demonstration Project
NCT01973556
Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension
NCT01202175
Continuous Femoral Nerve Blocks: Relative Effects of Basal Infusion and Bolus Doses on Sensory and Motor Function
NCT01144559
Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer
NCT01138553
The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
NCT01123161
mDiet: A Text Message Intervention for Weight Loss
NCT01171586
Reducing Breast Cancer Recurrence With Weight Loss
NCT01112839
Texting to Improve Adherence in HIV+ With Bipolar Disorder
NCT02090634
Clinical Trials Education Program for Hispanic Americans
NCT02083770
Hypertonic Saline as Therapy for Pediatric Concussion
NCT01612494
Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
NCT01066364
The Adrenal Contribution to Androgen Production in Girls During Puberty
NCT01062568
Effects of Catheter Tip Location Relative to the Femoral Nerve on Sensory and Motor Function
NCT01263249
Treating Insomnia & Nightmares After Trauma: Impact on Symptoms & Quality of Life
NCT01009112
Epithelial Healing and Visual Outcomes Using Omega-3 Therapy Before and After Photorefractive Keratectomy (PRK) Surgery
NCT01059019
Safety Study of External Counterpulsation as a Treatment for Acute Ischemic Stroke
NCT00983749
Per-Oral Endoscopic Myotomy
NCT01402518
Planned CORR: Planned Care for Obesity and Risk Reduction
NCT01134029
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 90 |
| Phase 3 | 22 |
| Phase 4 | 82 |
Therapeutic Areas
What is open in the University of California, San Diego pipeline
143 recruiting of 775 indexed (18% open); 499 completed (64%).
Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).
Top condition: Anorexia Nervosa (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Diego: open-pipeline peers nationwide
Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 775 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- University of Utah · 818 trials · 17% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Neurocrine Biosciences · 18% recruiting · 65 trials
- Thomas Jefferson University · 18% recruiting · 292 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
Related
What to do with this University of California, San Diego page
775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.
- 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.